- Sorrento's ( NASDAQ: SRNE ) unit Scilex Holding signed a distribution agreement for its non-opioid pain drug ZTlido with CH Trading Group, for certain territories including Middle East and North Africa.
- "We are pleased to work with CH Trading to help support us through the processes of obtaining global Halal certification as well as regulatory approval in the overseas designated territories," said Scilex CEO Jaisim Shah.
- Scilex is currently in the middle of a merger with SPAC Vickers Vantage I ( NASDAQ: VCKA ) and will go public on Nasdaq under the symbol SCLX.
For further details see:
Sorrento's unit Scilex inks distribution deal for pain drug ZTlido with CH Trading